title: Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?
abstract: West Nile virus (WNV)-induced encephalitis has been a public health concern in North America over the past decade. No therapeutics or vaccines are available for human use. Studies in animal models have provided important information for investigations of WNV pathogenesis and the host immune response in humans. This article will give an overview of the role of γδ T cells, one of the non-classical T cell subsets in the murine model of WNV encephalitis.
authors.affiliation: Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA. ti1wang@utmb.edu
authors.forename: Tian
authors.initials: T
authors.lastname: Wang
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000502:physiology*; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000473:pathology* / Q000821:virology; D014901:West Nile Fever / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D014902:West Nile virus / Q000276:immunology* / Q000472:pathogenicity
chemical_list: D016692:Receptors, Antigen, T-Cell, gamma-delta
references.citation: J Virol. 2006 Mar;80(6):2913-23
references.pmid: 16501100
references.citation: FASEB J. 2008 Jul;22(7):2198-205
references.pmid: 18299333
references.citation: J Immunol. 2005 Nov 1;175(9):5656-65
references.pmid: 16237055
references.citation: J Invest Dermatol. 2006 Jan;126(1):25-31
references.pmid: 16417214
references.citation: J Invest Dermatol. 2001 Sep;117(3):702-9
references.pmid: 11564180
references.citation: Emerg Infect Dis. 2002 Jan;8(1):107-8
references.pmid: 11749765
references.citation: J Exp Med. 1997 Jun 2;185(11):1969-75
references.pmid: 9166426
references.citation: J Exp Med. 2002 Dec 16;196(12):1575-84
references.pmid: 12486100
references.citation: J Neuroimmunol. 2002 Jun;127(1-2):106-14
references.pmid: 12044981
references.citation: J Neuroimmunol. 2002 Jul;128(1-2):58-68
references.pmid: 12098511
references.citation: Nat Med. 2004 Dec;10(12):1366-73
references.pmid: 15558055
references.citation: Lancet Infect Dis. 2002 Sep;2(9):519-29
references.pmid: 12206968
references.citation: Annu Rev Entomol. 2008;53:61-81
references.pmid: 17645411
references.citation: Nature. 1986 Jul 10-16;322(6075):179-81
references.pmid: 3487737
references.citation: J Immunol. 2005 Apr 15;174(8):4678-87
references.pmid: 15814692
references.citation: Immunology. 2000 Feb;99(2):187-94
references.pmid: 10692035
references.citation: J Immunol. 2008 Aug 1;181(3):2084-91
references.pmid: 18641347
references.citation: Ann N Y Acad Sci. 2001 Dec;951:172-8
references.pmid: 11797775
references.citation: Nat Rev Immunol. 2002 Sep;2(9):675-87
references.pmid: 12209136
references.citation: Immunol Cell Biol. 2003 Jun;81(3):230-6
references.pmid: 12752688
references.citation: J Virol. 2006 Jun;80(11):5338-48
references.pmid: 16699014
references.citation: J Leukoc Biol. 2005 Jan;77(1):67-70
references.pmid: 15498816
references.citation: Immunity. 2009 Feb 20;30(2):242-53
references.pmid: 19200759
references.citation: Chem Immunol. 2001;79:99-138
references.pmid: 11478158
references.citation: J Immunol. 2008 May 15;180(10):6760-7
references.pmid: 18453596
references.citation: Immunol Cell Biol. 1991 Apr;69 ( Pt 2):71-80
references.pmid: 1680803
references.citation: J Gen Virol. 1987 Jul;68 ( Pt 7):2001-6
references.pmid: 3496425
references.citation: Immunology. 2004 Jul;112(3):369-77
references.pmid: 15196204
references.citation: J Exp Med. 2003 Dec 15;198(12):1853-62
references.pmid: 14662909
references.citation: J Virol. 2003 Dec;77(24):13323-34
references.pmid: 14645588
references.citation: J Virol. 2006 Dec;80(24):12060-9
references.pmid: 17035323
references.citation: J Immunol. 2007 Oct 15;179(8):5576-83
references.pmid: 17911645
references.citation: J Immunol. 2000 Dec 1;165(11):6472-9
references.pmid: 11086087
references.citation: BMJ. 2002 Sep 14;325(7364):566
references.pmid: 12228130
references.citation: FEMS Immunol Med Microbiol. 2008 Jul;53(2):275-83
references.pmid: 18513355
references.citation: MMWR Morb Mortal Wkly Rep. 2002 Dec 20;51(50):1133-5
references.pmid: 12537288
references.citation: PLoS One. 2007 Nov 14;2(11):e1171
references.pmid: 18000543
references.citation: Immunol Lett. 2008 Dec 22;121(2):87-92
references.pmid: 18840468
references.citation: J Virol. 2005 Nov;79(21):13350-61
references.pmid: 16227257
references.citation: Microbes Infect. 1999 Mar;1(3):203-12
references.pmid: 10801231
references.citation: Clin Immunol. 2002 Jun;103(3 Pt 1):296-302
references.pmid: 12173304
references.citation: Virology. 2007 Oct 25;367(2):307-23
references.pmid: 17610927
references.citation: J Virol. 2001 May;75(9):4040-7
references.pmid: 11287553
references.citation: J Clin Invest. 2007 Oct;117(10):3059-66
references.pmid: 17909632
references.citation: Am J Ophthalmol. 2003 Oct;136(4):733-5
references.pmid: 14516816
references.citation: J Immunol. 2001 Jun 1;166(11):6784-94
references.pmid: 11359837
references.citation: J Immunol. 2004 Aug 1;173(3):1587-95
references.pmid: 15265886
references.citation: Arch Virol. 1996;141(3-4):459-69
references.pmid: 8645088
references.citation: J Exp Med. 2005 Jul 18;202(2):203-7
references.pmid: 16027234
references.citation: Science. 2002 Mar 22;295(5563):2255-8
references.pmid: 11910108
references.citation: Viral Immunol. 2003;16(3):259-78
references.pmid: 14583143
references.citation: J Immunol. 2006 Aug 1;177(3):1825-32
references.pmid: 16849493
references.citation: J Immunol. 2003 Sep 1;171(5):2524-31
references.pmid: 12928402
references.citation: J Virol. 2003 Dec;77(24):13203-13
references.pmid: 14645577
references.citation: Emerg Infect Dis. 2001 Jul-Aug;7(4):714-21
references.pmid: 11585537
references.citation: J Gen Virol. 1989 Mar;70 ( Pt 3):565-73
references.pmid: 2543751
references.citation: Nat Med. 2002 Jan;8(1):54-60
references.pmid: 11786907
references.citation: J Exp Med. 2002 Jan 7;195(1):43-9
references.pmid: 11781364
references.citation: J Virol. 2008 Nov;82(21):10349-58
references.pmid: 18715906
references.citation: Ann N Y Acad Sci. 2001 Dec;951:286-97
references.pmid: 11797785
references.citation: Vaccine. 2006 Sep 29;24(40-41):6392-404
references.pmid: 16831498
references.citation: Annu Rev Immunol. 2001;19:65-91
references.pmid: 11244031
references.citation: PLoS Pathog. 2009 Oct;5(10):e1000610
references.pmid: 19816558
references.citation: Arch Virol. 1994;137(3-4):355-70
references.pmid: 7944955
references.citation: J Nutr. 2009 Mar;139(3):598-602
references.pmid: 19141700
references.citation: FEMS Immunol Med Microbiol. 2011 Nov;63(2):183-92
references.pmid: 22077221
references.citation: J Clin Invest. 2001 Nov;108(9):1349-57
references.pmid: 11696580
references.citation: Annu Rev Immunol. 2000;18:975-1026
references.pmid: 10837080
references.citation: MMWR Morb Mortal Wkly Rep. 2002 Oct 4;51(39):877-8
references.pmid: 12375687
references.citation: J Infect Dis. 2004 Feb 15;189(4):669-76
references.pmid: 14767821
references.citation: Ann N Y Acad Sci. 2001 Dec;951:84-93
references.pmid: 11797807
references.citation: J Neurosci Res. 1990 Mar;25(3):345-52
references.pmid: 1691307
references.citation: J Invest Dermatol. 2000 Mar;114(3):560-8
references.pmid: 10692118
references.citation: FEMS Immunol Med Microbiol. 2010 Jun 1;59(1):71-80
references.pmid: 20337718
references.citation: J Virol. 2008 Jan;82(2):609-16
references.pmid: 17977974
references.citation: J Immunol. 2000 Oct 15;165(8):4174-81
references.pmid: 11035049
references.citation: J Immunol. 2004 Sep 15;173(6):3660-7
references.pmid: 15356111